SARA BUSCH: Open Payments
NPI 1669007100 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 31 payments from 14 companies in 2025. Trend: 2023 $629 · 2024 $1,936 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| Mirum Pharmaceuticals, Inc. | 1 | $35 |
| Janssen Biotech, Inc. | 2 | $35 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Boston Scientific Corporation | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 4 | $20 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $19 |
Products named: RINVOQ, ENTYVIO, Livmarli, TREMFYA, ZENPEP, DUPIXENT, SKYRIZI, Intracept.
Industry payments across MO — which companies pay providers there.
